Non-alcoholic fatty liver disease (NAFLD) is a common condition characterised by excessive fat accumulation in the liver of individuals who consume little to no alcohol (typically defined as less than 14 units per week in the UK)
If you or someone you care about has experienced severe health issues after taking Ozempic, Wegovy, Mounjaro, or any similar weight loss medications, contact our GLP-1 lawyers serving Louisiana about filing a lawsuit
These are things kids can benefit from if we teach them creatively. Growing commitment to integrated care Wellstars primary care model continues to evolve to meet the behavioral health needs of patients throughout their life
Published in 2019, it did not show superiority in reducing MACE, but it provided valuable evidence regarding the safety and oral delivery of GLP-1 receptor agonists, expanding treatment options for patients with T2D (43)
You can find previous posts in the Employer Coverage archive Please like and suggest this newsletter to friends and colleagues